Buspirone EP Impurity L
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

21098-11-3Buspirone EP Impurity L

● In Stock

Catalogue No.:VL249007
CAS No.:21098-11-3
Mol. Formula:C13H20ClNO2
Mol. Weight:257.76 g/mol

Order Online

UNIT PRICE QTY STATUS ACTION
100 mg $199.00
● In Stock
We accept Credit Card Icons

Additional information on CAS 21098-11-3

Parent drug

Buspirone

IUPAC Name

8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione

Pharmacopoeial Synonyms

Buspirone Related Compound L

Other Synonyms

N/A

Smiles

O=C(N(CCCCCl)C(C1)=O)CC21CCCC2

InChI

InChI=1S/C13H20ClNO2/c14-7-3-4-8-15-11(16)9-13(10-12(15)17)5-1-2-6-13/h1-10H2

Shipping Condition

Ambient Temperature

Description

Buspirone Related Compound L, also listed as Buspirone EP Impurity L, is a chlorinated buspirone-derived process impurity identified by CAS 21098-11-3. With molecular formula C13H20ClNO2 and molecular weight 257.76 g/mol, it represents a structurally defined heteroatom-containing analog relevant to impurity profiling of buspirone hydrochloride materials. Its origin is typically associated with synthetic route side products or halogen-containing intermediates rather than simple oxidative degradation. Characterization and quantification generally require LC-MS/MS for selectivity, with complementary HPLC-UV or GC-MS confirmation when volatility and derivatization permit. As a defined organic impurity, it is assessed within pharmacopoeial and ICH impurity control frameworks.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url